United States Biotechnology & Medical Research

9 Meters Biopharma Inc (NMTR)

Track

Ticker: NMTR Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
BETHANY SENSENIG Officer Officer
Transaction date
Proposed sale
Price
251.33
Quantity 57,803
Value US$3,320,987
3.6
Sirgo Mark A Director Non-Executive Director
Transaction date
Proposed sale
Price
257.16
Quantity 49,306
Value US$3,236,815
3.4
Bethany L. Sensenig Officer Officer
Transaction date
Proposed sale
Price
283.71
Quantity 1,045
Value US$653,560
3.4
Sensenig Bethany Chief Financial Officer Officer
Transaction date
Sale
Price
1.21
Quantity 9,100 -18.1%
Value US$11,011
Temperato John Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.23
Quantity 125,000 +9.6%
Value US$28,462
3.6
Sirgo Mark A Non-Executive Director
Transaction date
Purchase
Price
0.25
Quantity 175,000 +13.7%
Value US$42,962
2.3
Constantino Michael T. Non-Executive Director
Transaction date
Purchase
Price
0.48
Quantity 16,000 +35.9%
Value US$7,608
3.6
Sirgo Mark A Non-Executive Director
Transaction date
Purchase
Price
0.47
Quantity 106,383 +8.3%
Value US$50,000
Temperato John Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.45
Quantity 50,000 +4.0%
Value US$22,285
3.6
Sirgo Mark A Non-Executive Director
Transaction date
Purchase
Price
0.58
Quantity 86,450 +7.2%
Value US$50,002
Temperato John Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.56
Quantity 100,000 +8.7%
Value US$55,590
3.6
Sirgo Mark A Non-Executive Director
Transaction date
Purchase
Price
0.89
Quantity 50,000 +4.2%
Value US$44,500
3.6
Sirgo Mark A Non-Executive Director
Transaction date
Purchase
Price
1.06
Quantity 20,000 +1.7%
Value US$21,200
Temperato John Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.05
Quantity 50,000 +4.5%
Value US$52,500
2.3
Constantino Michael T. Non-Executive Director
Transaction date
Purchase
Price
1.14
Quantity 18,000 +52.8%
Value US$20,520
3.6
Sirgo Mark A Non-Executive Director
Transaction date
Purchase
Price
1.00
Quantity 300,000 +38.8%
Value US$300,000
Sitar Edward J Chief Financial Officer Officer
Transaction date
Purchase
Price
1.00
Quantity 50,000 +38.7%
Value US$50,000
Temperato John Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.65
Quantity 153,846 +18.7%
Value US$100,000
Sitar Edward J Chief Financial Officer Officer
Transaction date
Purchase
Price
0.65
Quantity 61,538 +90.8%
Value US$40,000
3.6
Sirgo Mark A Non-Executive Director
Transaction date
Purchase
Price
0.65
Quantity 230,769 +42.5%
Value US$150,000
3.6
Sirgo Mark A Non-Executive Director
Transaction date
Purchase
Price
0.65
Quantity 21,485 +inf%
Value US$14,004
3.6
Sirgo Mark A Non-Executive Director
Transaction date
Purchase
Price
0.68
Quantity 77,000 +16.7%
Value US$52,360
3.6
Sirgo Mark A Non-Executive Director
Transaction date
Purchase
Price
0.60
Quantity 50,000 +12.1%
Value US$30,000
Temperato John Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.69
Quantity 70,000 +12.8%
Value US$48,300
2.3
Constantino Michael T. Non-Executive Director
Transaction date
Purchase
Price
0.75
Quantity 34,108 +inf%
Value US$25,581
3.6
Sirgo Mark A Non-Executive Director
Transaction date
Purchase
Price
0.56
Quantity 100,000 +32.1%
Value US$56,000
Temperato John Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.57
Quantity 35,000 +6.9%
Value US$19,831
3.6
Sirgo Mark A Non-Executive Director
Transaction date
Purchase
Price
0.60
Quantity 17,943 +45.5%
Value US$10,721
Temperato John Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.60
Quantity 10,000 +25.4%
Value US$5,971
3.3
Laumas Sandeep CEO, Executive Chairman Executive Director
Transaction date
Purchase
Price
1.15
Quantity 4,000 +28.6%
Value US$4,600
3.3
Laumas Sandeep CEO, Executive Chairman Executive Director
Transaction date
Purchase
Price
1.22
Quantity 591 +4.4%
Value US$721
3.3
Laumas Sandeep CEO, Executive Chairman Executive Director
Transaction date
Purchase
Price
1.21
Quantity 409 +3.1%
Value US$495
Madan Jay P. President Executive Director
Transaction date
Purchase
Price
1.32
Quantity 5,000 +6.3%
Value US$6,600
Proujansky Roy
Transaction date
Purchase
Price
1.28
Quantity 1,000 +71.4%
Value US$1,280
3.3
Laumas Sandeep CEO, Executive Chairman Executive Director
Transaction date
Purchase
Price
1.38
Quantity 5,000 +62.5%
Value US$6,900
Proujansky Roy Non-Executive Director
Transaction date
Purchase
Price
2.63
Quantity 1,400 +inf%
Value US$3,682
Laumas Sandeep Executive Chairman Executive Director
Transaction date
Purchase
Price
2.63
Quantity 1,000 +14.3%
Value US$2,630
Laumas Sandeep Executive Chairman Executive Director
Transaction date
Purchase
Price
2.62
Quantity 1,000 +16.7%
Value US$2,620
Laumas Sandeep Executive Chairman Executive Director
Transaction date
Purchase
Price
2.64
Quantity 1,000 +20.0%
Value US$2,640
Laumas Sandeep Executive Chairman Executive Director
Transaction date
Purchase
Price
2.56
Quantity 2,000 +66.7%
Value US$5,120
Laumas Sandeep Executive Chairman Executive Director
Transaction date
Purchase
Price
2.55
Quantity 1,000 +50.0%
Value US$2,550
Prior Christopher P. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.75
Quantity 5,000 +248.9%
Value US$13,750
Prior Christopher P. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.82
Quantity 200 +11.1%
Value US$1,164
Prior Christopher P. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
6.13
Quantity 500 +38.2%
Value US$3,065
Laumas Sandeep Executive Chairman Executive Director
Transaction date
Purchase
Price
6.10
Quantity 500 +33.3%
Value US$3,050
Prior Christopher P. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.20
Quantity 309 +30.9%
Value US$1,607
Laumas Sandeep Executive Chairman Executive Director
Transaction date
Purchase
Price
5.24
Quantity 500 +200.0%
Value US$2,620
Prior Christopher P. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
4.93
Quantity 1,000 +inf%
Value US$4,930
Laumas Sandeep Executive Chairman Executive Director
Transaction date
Purchase
Price
5.08
Quantity 405 +68.1%
Value US$2,057
Laumas Sandeep Executive Chairman Executive Director
Transaction date
Purchase
Price
5.07
Quantity 95 +19.0%
Value US$482
Laumas Sandeep Executive Chairman Executive Director
Transaction date
Purchase
Price
4.88
Quantity 250 +100.0%
Value US$1,220
Laumas Sandeep Executive Chairman Executive Director
Transaction date
Purchase
Price
4.90
Quantity 0
Value US$0
Almenoff June Sherie COO and Chief Medical Officer Officer
Transaction date
Purchase
Price
4.94
Quantity 100 +12.5%
Value US$494
Almenoff June Sherie COO and Chief Medical Officer Officer
Transaction date
Purchase
Price
4.96
Quantity 253 +46.3%
Value US$1,255
Almenoff June Sherie COO and Chief Medical Officer Officer
Transaction date
Purchase
Price
4.90
Quantity 47 +9.4%
Value US$230
Almenoff June Sherie COO and Chief Medical Officer Officer
Transaction date
Purchase
Price
4.85
Quantity 500 +55.6%
Value US$2,425
Almenoff June Sherie COO and Chief Medical Officer Officer
Transaction date
Purchase
Price
4.99
Quantity 400 +400.0%
Value US$1,996
Almenoff June Sherie COO and Chief Medical Officer Officer
Transaction date
Purchase
Price
4.85
Quantity 100 +inf%
Value US$485
CLARKE DAVID H Former CEO and Director Executive Director
Transaction date
Purchase
Price
0.35
Quantity 300,000 +21.1%
Value US$105,000
CLARKE DAVID H Former CEO and Director Executive Director
Transaction date
Purchase
Price
0.45
Quantity 366,159 +36.3%
Value US$164,772
CLARKE DAVID H Former CEO and Director Executive Director
Transaction date
Purchase
Price
0.58
Quantity 172,414 +25.0%
Value US$100,000
CLARKE DAVID H Former CEO and Director Executive Director
Transaction date
Purchase
Price
1.50
Quantity 70,000 +11.3%
Value US$105,000
CLARKE DAVID H Former CEO and Director Executive Director
Transaction date
Purchase
Price
4.50
Quantity 15,000 +3.5%
Value US$67,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-21 2023-07-21 PrS Proposed sale
3.4
BETHANY SENSENIG

Officer

Officer
57,803
251.33
US$3,320,987 		57,803 251.33 US$3,320,987
2023-07-19 2023-07-19 PrS Proposed sale
3.6
Sirgo Mark A

Director

Non-Executive Director
49,306
257.16
US$3,236,815 		49,306 257.16 US$3,236,815
2023-04-21 2023-04-21 PrS Proposed sale
3.4
Bethany L. Sensenig

Officer

Officer
1,045
283.71
US$653,560 		1,045 283.71 US$653,560
2023-04-21 2023-04-21 S Sale
3.4
Sensenig Bethany

Chief Financial Officer

Officer
9,100 -18.1%
1.21
US$11,011 		9,100 -18.1% 1.21 US$11,011
2022-07-08 2022-07-06 B Purchase
Temperato John

Chief Executive Officer

Executive Director
125,000 +9.6%
0.23
US$28,462 		125,000 +9.6% 0.23 US$28,462
2022-07-06 2022-07-01 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
175,000 +13.7%
0.25
US$42,962 		175,000 +13.7% 0.25 US$42,962
2022-05-24 2022-05-23 B Purchase
2.3
Constantino Michael T.
Non-Executive Director
16,000 +35.9%
0.48
US$7,608 		16,000 +35.9% 0.48 US$7,608
2022-05-19 2022-05-18 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
106,383 +8.3%
0.47
US$50,000 		106,383 +8.3% 0.47 US$50,000
2022-05-19 2022-05-18 B Purchase
Temperato John

Chief Executive Officer

Executive Director
50,000 +4.0%
0.45
US$22,285 		50,000 +4.0% 0.45 US$22,285
2022-03-07 2022-03-03 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
86,450 +7.2%
0.58
US$50,002 		86,450 +7.2% 0.58 US$50,002
2022-03-04 2022-03-03 B Purchase
Temperato John

Chief Executive Officer

Executive Director
100,000 +8.7%
0.56
US$55,590 		100,000 +8.7% 0.56 US$55,590
2021-12-03 2021-12-02 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
50,000 +4.2%
0.89
US$44,500 		50,000 +4.2% 0.89 US$44,500
2021-11-22 2021-11-18 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
20,000 +1.7%
1.06
US$21,200 		20,000 +1.7% 1.06 US$21,200
2021-11-19 2021-11-18 B Purchase
Temperato John

Chief Executive Officer

Executive Director
50,000 +4.5%
1.05
US$52,500 		50,000 +4.5% 1.05 US$52,500
2021-08-26 2021-08-24 B Purchase
2.3
Constantino Michael T.
Non-Executive Director
18,000 +52.8%
1.14
US$20,520 		18,000 +52.8% 1.14 US$20,520
2021-04-06 2021-04-05 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
300,000 +38.8%
1.00
US$300,000 		300,000 +38.8% 1.00 US$300,000
2021-04-06 2021-04-05 B Purchase
Sitar Edward J

Chief Financial Officer

Officer
50,000 +38.7%
1.00
US$50,000 		50,000 +38.7% 1.00 US$50,000
2020-12-17 2020-12-15 B Purchase
Temperato John

Chief Executive Officer

Executive Director
153,846 +18.7%
0.65
US$100,000 		153,846 +18.7% 0.65 US$100,000
2020-12-17 2020-12-15 B Purchase
Sitar Edward J

Chief Financial Officer

Officer
61,538 +90.8%
0.65
US$40,000 		61,538 +90.8% 0.65 US$40,000
2020-12-17 2020-12-15 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
230,769 +42.5%
0.65
US$150,000 		230,769 +42.5% 0.65 US$150,000
2020-09-14 2020-09-11 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
21,485 +inf%
0.65
US$14,004 		21,485 +inf% 0.65 US$14,004
2020-09-14 2020-09-11 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
77,000 +16.7%
0.68
US$52,360 		77,000 +16.7% 0.68 US$52,360
2020-09-14 2020-09-10 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
50,000 +12.1%
0.60
US$30,000 		50,000 +12.1% 0.60 US$30,000
2020-08-24 2020-08-21 B Purchase
Temperato John

Chief Executive Officer

Executive Director
70,000 +12.8%
0.69
US$48,300 		70,000 +12.8% 0.69 US$48,300
2020-08-21 2020-08-20 B Purchase
2.3
Constantino Michael T.
Non-Executive Director
34,108 +inf%
0.75
US$25,581 		34,108 +inf% 0.75 US$25,581
2020-08-18 2020-08-17 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
100,000 +32.1%
0.56
US$56,000 		100,000 +32.1% 0.56 US$56,000
2020-08-17 2020-08-17 B Purchase
Temperato John

Chief Executive Officer

Executive Director
35,000 +6.9%
0.57
US$19,831 		35,000 +6.9% 0.57 US$19,831
2020-06-16 2020-06-15 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
17,943 +45.5%
0.60
US$10,721 		17,943 +45.5% 0.60 US$10,721
2020-06-15 2020-06-15 B Purchase
Temperato John

Chief Executive Officer

Executive Director
10,000 +25.4%
0.60
US$5,971 		10,000 +25.4% 0.60 US$5,971
2019-07-01 2019-06-28 B Purchase
3.3
Laumas Sandeep

CEO, Executive Chairman

Executive Director
4,000 +28.6%
1.15
US$4,600 		4,000 +28.6% 1.15 US$4,600
2019-06-17 2019-06-13 B Purchase
3.3
Laumas Sandeep

CEO, Executive Chairman

Executive Director
591 +4.4%
1.22
US$721 		591 +4.4% 1.22 US$721
2019-06-17 2019-06-13 B Purchase
3.3
Laumas Sandeep

CEO, Executive Chairman

Executive Director
409 +3.1%
1.21
US$495 		409 +3.1% 1.21 US$495
2019-06-03 2019-05-30 B Purchase
Madan Jay P.

President

Executive Director
5,000 +6.3%
1.32
US$6,600 		5,000 +6.3% 1.32 US$6,600
2019-05-28 2019-05-24 B Purchase
Proujansky Roy
1,000 +71.4%
1.28
US$1,280 		1,000 +71.4% 1.28 US$1,280
2019-05-23 2019-05-22 B Purchase
3.3
Laumas Sandeep

CEO, Executive Chairman

Executive Director
5,000 +62.5%
1.38
US$6,900 		5,000 +62.5% 1.38 US$6,900
2018-12-03 2018-11-30 B Purchase Proujansky Roy Non-Executive Director
1,400 +inf%
2.63
US$3,682 		1,400 +inf% 2.63 US$3,682
2018-12-03 2018-11-30 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
1,000 +14.3%
2.63
US$2,630 		1,000 +14.3% 2.63 US$2,630
2018-12-03 2018-11-30 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
1,000 +16.7%
2.62
US$2,620 		1,000 +16.7% 2.62 US$2,620
2018-12-03 2018-11-30 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
1,000 +20.0%
2.64
US$2,640 		1,000 +20.0% 2.64 US$2,640
2018-11-29 2018-11-29 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
2,000 +66.7%
2.56
US$5,120 		2,000 +66.7% 2.56 US$5,120
2018-11-29 2018-11-29 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
1,000 +50.0%
2.55
US$2,550 		1,000 +50.0% 2.55 US$2,550
2018-11-29 2018-11-29 B Purchase Prior Christopher P.

Chief Executive Officer

Executive Director
5,000 +248.9%
2.75
US$13,750 		5,000 +248.9% 2.75 US$13,750
2018-09-14 2018-09-14 B Purchase Prior Christopher P.

Chief Executive Officer

Executive Director
200 +11.1%
5.82
US$1,164 		200 +11.1% 5.82 US$1,164
2018-09-13 2018-09-12 B Purchase Prior Christopher P.

Chief Executive Officer

Executive Director
500 +38.2%
6.13
US$3,065 		500 +38.2% 6.13 US$3,065
2018-09-10 2018-09-07 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
500 +33.3%
6.10
US$3,050 		500 +33.3% 6.10 US$3,050
2018-08-30 2018-08-30 B Purchase Prior Christopher P.

Chief Executive Officer

Executive Director
309 +30.9%
5.20
US$1,607 		309 +30.9% 5.20 US$1,607
2018-08-30 2018-08-30 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
500 +200.0%
5.24
US$2,620 		500 +200.0% 5.24 US$2,620
2018-08-28 2018-08-28 B Purchase Prior Christopher P.

Chief Executive Officer

Executive Director
1,000 +inf%
4.93
US$4,930 		1,000 +inf% 4.93 US$4,930
2018-08-28 2018-08-28 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
405 +68.1%
5.08
US$2,057 		405 +68.1% 5.08 US$2,057
2018-08-28 2018-08-28 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
95 +19.0%
5.07
US$482 		95 +19.0% 5.07 US$482
2018-08-28 2018-08-28 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
250 +100.0%
4.88
US$1,220 		250 +100.0% 4.88 US$1,220
2018-08-28 2018-08-28 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
0
4.90
US$0 		0 4.90 US$0
2018-08-28 2018-08-27 B Purchase Almenoff June Sherie

COO and Chief Medical Officer

Officer
100 +12.5%
4.94
US$494 		100 +12.5% 4.94 US$494
2018-08-28 2018-08-27 B Purchase Almenoff June Sherie

COO and Chief Medical Officer

Officer
253 +46.3%
4.96
US$1,255 		253 +46.3% 4.96 US$1,255
2018-08-28 2018-08-27 B Purchase Almenoff June Sherie

COO and Chief Medical Officer

Officer
47 +9.4%
4.90
US$230 		47 +9.4% 4.90 US$230
2018-08-28 2018-08-24 B Purchase Almenoff June Sherie

COO and Chief Medical Officer

Officer
500 +55.6%
4.85
US$2,425 		500 +55.6% 4.85 US$2,425
2018-08-28 2018-08-24 B Purchase Almenoff June Sherie

COO and Chief Medical Officer

Officer
400 +400.0%
4.99
US$1,996 		400 +400.0% 4.99 US$1,996
2018-08-28 2018-08-24 B Purchase Almenoff June Sherie

COO and Chief Medical Officer

Officer
100 +inf%
4.85
US$485 		100 +inf% 4.85 US$485
2018-03-13 2018-01-26 B Purchase CLARKE DAVID H

Former CEO and Director

Executive Director
300,000 +21.1%
0.35
US$105,000 		300,000 +21.1% 0.35 US$105,000
2018-03-13 2017-11-29 B Purchase CLARKE DAVID H

Former CEO and Director

Executive Director
366,159 +36.3%
0.45
US$164,772 		366,159 +36.3% 0.45 US$164,772
2018-03-13 2017-06-23 B Purchase CLARKE DAVID H

Former CEO and Director

Executive Director
172,414 +25.0%
0.58
US$100,000 		172,414 +25.0% 0.58 US$100,000
2018-03-13 2017-03-16 B Purchase CLARKE DAVID H

Former CEO and Director

Executive Director
70,000 +11.3%
1.50
US$105,000 		70,000 +11.3% 1.50 US$105,000
2018-03-13 2016-07-13 B Purchase CLARKE DAVID H

Former CEO and Director

Executive Director
15,000 +3.5%
4.50
US$67,500 		15,000 +3.5% 4.50 US$67,500
Explore more

More insider trading research around 9 Meters Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America